Can-Fite BioPharma (CANF) Institutional Ownership → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free CANF Stock Alerts $1.98 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for Can-Fite BioPharma (NYSE:CANF)CurrentInstitutional OwnershipPercentage21.00%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$383.77KNumber ofInstitutional Sellers(last 12 months)0 Get CANF Insider Trade Alerts Want to know when executives and insiders are buying or selling Can-Fite BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CANF Institutional Buying and Selling by Quarter Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Can-Fite BioPharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC154,363$340K0.0%N/A4.361% 1/17/2024Schechter Investment Advisors LLC20,077$44K0.0%N/A0.567% 2/10/2022Acadian Asset Management LLC28,601$36K0.0%-75.1%0.105% 11/16/2021Cetera Advisor Networks LLC130,776$217K0.0%-16.9%0.607% 10/15/2021Fifth Third Bancorp30,000$50K0.0%N/A0.149% 8/6/2021StoneX Group Inc.40,000$91K0.0%N/A0.233% 5/21/2021Citadel Advisors LLC60,077$148K0.0%N/A0.349% 5/19/2021Virtu Financial LLC46,294$114K0.0%-37.5%0.269% 5/18/2021Citadel Advisors LLC60,077$148K0.0%N/A0.349% 5/18/2021Jane Street Group LLC10,665$26K0.0%N/A0.062% 5/14/2021XTX Topco Ltd11,205$28K0.0%N/A0.065% 5/14/2021Stifel Financial Corp12,000$30K0.0%N/A0.070% 3/26/2021Susquehanna International Group LLP15,323$27K0.0%N/A0.090% 2/24/2021Virtu Financial LLC74,052$132K0.0%+445.7%0.479% 2/10/2021Renaissance Technologies LLC118,894$212K0.0%+812.7%0.769% 8/7/2020Virtu Financial LLC31,805$63K0.0%N/A0.206% (Data available from 1/1/2016 forward) CANF Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CANF shares? During the previous two years, the following institutional investors and hedge funds held shares of Can-Fite BioPharma shares: Armistice Capital LLC ($340K), Schechter Investment Advisors LLC ($44K).Learn more on CANF's institutional investors. What percentage of Can-Fite BioPharma stock is owned by institutional investors? 21.00% of Can-Fite BioPharma stock is owned by institutional investors. Learn more on CANF's institutional investor holdings. Which institutional investors have been buying Can-Fite BioPharma stock? The following institutional investors have purchased Can-Fite BioPharma stock in the last 24 months: Armistice Capital LLC ($154.36K), and Schechter Investment Advisors LLC ($20.08K). How much institutional buying is happening at Can-Fite BioPharma? Institutional investors have bought a total of 174,440 shares in the last 24 months. This purchase volume represents approximately $383.77K in transactions. Related Companies: Tenax Therapeutics Major Shareholders Clever Leaves Major Shareholders Pulmatrix Major Shareholders Trevena Major Shareholders Cadrenal Therapeutics Major Shareholders Enveric Biosciences Major Shareholders eFFECTOR Therapeutics Major Shareholders Lixte Biotechnology Major Shareholders Kazia Therapeutics Major Shareholders Adial Pharmaceuticals Major Shareholders This page (NYSE:CANF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can-Fite BioPharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
